Novel PET Imaging Agent Accurately IDs Clear Cell Renal Cancers

An investigational PET imaging agent, identified clear cell renal cell carcinoma (ccRCC) with high sensitivity and specificity, according to results from the phase III ZIRCON trial.

Read More


Immediate Complete Revascularization Non-Inferior to Staged Procedure

Immediate complete revascularization was non-inferior to staged complete revascularization in patients who presented with acute coronary syndrome (ACS) and multivessel disease, according to BIOVASC trial findings.

Read More


Pulsed Field Afib Ablation Hits Endpoints in Pivotal Trial

A new atrial fibrillation (Afib; AF) technology, pulsed field ablation, appears to eliminate abnormal heart rhythms in most patients for at least a year, a researcher reported here.

Read More


Perioperative Chemo Matches Multimodal Tx for Locally Advanced Esophageal/GEJ Cancer

A short course of perioperative chemotherapy for locally advanced esophageal/gastroesophageal junction (GEJ) cancer led to outcomes similar to those achieved with more intensive multimodal therapy, according to a randomised trial reported here.

Read More


Bone Drug Reverses Damage in Hand Osteoarthritis

The osteoporosis drug denosumab (Prolia) not only stopped structural progression in patients with erosive osteoarthritis of the hand, but showed signs of reversing the damage, according to findings from a small trial.

Read More

About Us

GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. Gloreen G at GCG has vast experience and understanding of the specialist medical and diagnostic imaging market. This gives GCG the ability to ensure that you receive the very best salary and incentives package, including leave entitlements, days off, paid conferences and radiology expenses.